Subacute sclerosing panencephalitis. Diagnosis and drug treatment options

CNS Drugs

Volumn 7, Issue 2, 1997, Pages 111-120

  Anlar, Banu ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CIMETIDINE; CYTARABINE; IMMUNOGLOBULIN G; METHISOPRINOL;

BRAIN BIOPSY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL TRIAL; ELECTROENCEPHALOGRAM; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEASLES; PRIORITY JOURNAL; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0031057418     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199707020-00003     Document Type: Review

References (53)

1. Okuno Y, Nakao T, Ishida N, et al. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Int J Epidemiol 1989; 18: 684-9
2. Yalaz K, Anlar B, Renda Y, et al. Subacute sclerosing panencephalitis in Turkey: epidemiological features. J Trop Pediatr 1988; 34: 301-5
3. Hutchins S, Markowitz L, Atkinson W, et al. Measles outbreaks in the United States. 1987 through 1990. Pediatr Infect Dis J 1996; 15: 31-8
4. Risk WS, Haddad FS. The variable natural history of subacute sclerosing panencephalitis. Arch Neurol 1979 Oct; 36: 610-4
5. Case records of the Massachusetts General Hospital, case 25-1986. A 24-year-old woman with a three month history of progressive mental deterioration. N Engl J Med 1986; 314 (26): 1689-700
6. Anlar B, Yalaz K, Ustaçelebi Ş. Symptomes et signes cliniques, données du laboratoire dans 80 cas de panencéphalite sclérosante subaigue. Rev Neurol 1988; 144: 829-32
7. Radermecker J. Aspects électroencéphalographiques dans cas d'encéphalite subaigue. Acta Neurol Psychiatr Belg 1949; 49: 222-32
8. Markand ON, Panazi JG. The electroencephalogram in subacute sclerosing panencephalilis. Arch Neurol 1975 Nov; 32: 719-26
9. Takayama S, Iwasaki Y, Yamanouchi H, et al. Characteristic clinical features in a case of fulminant subacute sclerosing panencephalilis. Brain Dev 1994; 16: 132-5
10. Wirguin I, Steiner I, Kidron D, et al. Fulminant subacute sclerosing panencephalitis in association with pregnancy. Arch Neurol 1988 Dec; 45: 1324-5
11. Ishikawa A, Murayama T, Sakuma N, et al. Subacute sclerosing panencephalitis: atypical absence attacks as first symptom. Neurology 1981 Mar; 31: 311-5
12. Namer IJ, Tan E, Ciger A, et al. Crises épileptiques partielles complexes premier symptome d'une panencéphalite subaigue sclérosante. Rev Neurol 1986; 142 (12): 921-5
13. Gimenez-Roldan S, Martin M, Mateo D, et al. Preclinical EEG abnormalities in subacute sclerosing panencephalitis. Neurology 1981 Jun; 31: 763-7
14. Anlar B, Yalaz K, Ustaçelebi Ş. Clinical and laboralory findings in a series of subacute sclerosing panencephalitis. Turk J Pediatr 1988; 30: 85-92
15. Ohya T, Martinez JA, Jabbour JT, et al. Subacute sclerosing panencephalitis: correlation of clinical, neurophysiologic and neuropathologic findings. Neurology 1974 Mar; 24: 211-8
16. Silva CA, Paula-Barbosa MM, Pereira S, et al. Two cases of rapidly progressive subacute sclerosing panencephalitis: neuropathological findings. Arch Neurol 1981 Feb; 38: 109-13
17. Isaacson SH, Le H, Godec MS, et al. Cellular localization of measles virus in SSPE by in situ PCR: enhanced detection of widespread infection [abstract]. Neurology 1994 Apr; 44 Suppl. 2: A319
18. Cattaneo R, Schmid A, Eschle D, et al. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988; 55: 255-65
19. Baram TZ, Gonzalez-Gomez I, Xie ZD, et al. Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis. Ann Neurol 1994 Jul; 36: 103-8
20. Krawiecki NS, Dyken PR, Cammal TE, et al. Computed tomography of the brain in subacute sclerosing panencephalitis. Ann Neurol 1984 May; 15: 489-93
21. Anlar B, Saatçi I, Köse G, et al. MRI findings in subacute sclerosing panencephalitis. Neurology 1996; 47; 1278-83
22. Yagi S, Miura Y, Wakunami A, et al. Chronological SPECT studies of a patient with subacute sclerosing panencephalitis. Brain Dev 1993; 15 (2): 141-5
23. Mehta PD, Kulczyeki J, Patrick BA, et al. Effect of treatment on oligoclonal IgG hands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis. J Neurol Sci 1992; 109: 64-8
24. Cochereau-Massin I, Gaduric A, Reinert P, et al. Changes in the fundus in subacute sclerosing panencephalitis. J Fr Ophtalmol 1992; 15 (4): 255-61
25. Weil ML, Itabashi HH, Cremer NE, et al. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N Eng J Med 1975 May; 292: 994-8
26. Britton TC, Al-Sarraj S, Shaw C, et al. Sporadic Creutzfeld-Jakob disease in a 16-year-old in the UK [letter]. Lancet 1995 Oct 28; 11: 1155
27. Batteman D, Hilton D, Love S, et al. Sporadic Creutzfeld-Jakob disease in a 18-year-old in the UK [letter]. Lancet 1995 Oct 28; 11: 1155-6
28. Risk WS, Haddad FS, Chemali R. Substantial long-term improvement in subacute sclerosing panencephalitis: six cases from the Middle Fast and a review of the literature. Arch Neurol 1978 Aug; 35: 494-502
29. Panitch HS. Treatment of subacute sclerosing panencephalitis with interferon. In: Smith RA, editor. Interferon treatment of neurologic disorders. New York: Marcel Dekker, Inc, 1988: 187-207
30. Ohnishi H, Kosuzume H, Inaha H, et al. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections. Int J Immunopharmacol 1983; 5 (3): 181-96
31. Gadoth N, Kott E, Levin S, et al. The interferon system in SSPE and its response to isoprinosine. Brain Dev 1989; 11 (5): 308-12
32. Jones CE, Dyken PR, Huttenlocher PR, et al. Inosiplex therapy in SSPE: a multicentre non-randomised study in 98 patients. Lancet 1982 May; 1: 1034-7
33. The Inosiplex Research Committee. Clinical effects of MND-19 (inosiplex) on SSPE: a multi-institutional collaborative study. Brain Dev 1987; 9 (3): 270-82
34. Haddad FS, Risk WS. Isoprinosine treatment in 18 patients with SSPE. A controlled study. Ann Neurol 1980; 7: 185-8
35. DuRant RH, Dyken PR. The effect of inosiplex on the survival of subacute sclerosing panencephalilis. Neurology 1983; 33: 1053-5
36. Lebon P, Boutin B, Dulac O, et al. Interferon in acute and subacute encephalitis. BMJ 1988; 296: 9-11
37. Bye A, Balkwill F, Brigden D, et al. Use of interferon in the management of patients with subacute sclerosing panencephalitis. Dev Med Child Neurol 1985; 27: 170-5
38. Huttenlocher PR, Pichietti DL, Roos PR, et al. Intrathecal interferon in subacute sclerosing panencephalilis. Ann Neurol 1986 Mar; 19 (3): 303-5
39. Yalaz K, Anlar B, Oktem F, et al. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 1992; 42: 488-91
40. Gascon C, Yamani S, Crowell J, et al. Combined oral isoprinosine-intraventricular α-IFN therapy for subacute sclerosing panencephalitis. Brain Dev 1993; 15 (5): 346-55
41. Finter NB. The naming of cats-and alpha-interferons. Lancet 1996; 348: 348-9
42. Cianchelli C, Marrosu G, Fratta A, et al. Toxic effects of interferon after intraventricular administration in subacute sclerosing: panencephalitis [abstract]. Pediatr Neurol 1992; 8: 370
43. Anlar B, Yalaz K, Öktem F, et al. Long-term follow-up of subacute sclerosing panencephalitis patients treated with intraventricular α-interferon. Neurology. In press
44. Kuroki S, Tstsui T, Yoshioka M, et al. The effect of intraventricular interferon on subacute sclerosing panencephalitis. Brain Dev 1989; 11 (1): 65-9
45. Sobcyzk W, Pilkowska E, Iwinska-Buksowicz B, et al. Selective problems for catamnestic studies of SSPE patients (1980-1989). Neurol Neurochir Pol 1994; 28 (1 Suppl 1): 567-78
46. Sobcyzk W, Kulczycki J, Pilkowska E, et al. Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparations. Neurol Neurochir Pol 1991 Sep-Oct; 25 (5): 626-33
47. Anlar B, Gücüyener K, Imir T, et al. Cimetidine as an immunomodulator in subacute sclerosing panencephalitis: a double blind, placebo-controlled study. Pediatr Infect Dis J 1993; 12 (7): 578-81
48. Gürer YK, Kükner Ş, Sarica B. Intravenous γ-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediatr Neurol 1996; 14: 72-4
49. Al Rajeh S, Kabiraj MU, Al Fawaz I, et al. Can cytotoxic drugs cure SSPE? [letter] Lancet 1995 Aug; 346: 377
50. Anlar B, Yalaz K, Köse G, et al. Intravenous immunoglobulin in subacute sclerosing panencephalitis [abstract]. Epilepsia 1995; 36 Suppl. 3: S208
51. Koschel K, Brinckmann U, Hoyningen-Huene VV. Measles virus antisense sequences specifically cure cells persistently infected with measles virus. Virology 1995; 207: 168-78
52. Dyken PR, Swift A, DuRant RH. Long-term follow-up of patients with subucute sclerosing panencephalitis treated with inosiplex. Ann Neurol 1982 Apr; 11 (4): 354-63
53. Mehta PD, Kulczycki J, Mehta SP, et al. Increased levels of α-2 microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis. Clin Immunol Immunopathol 1992 Oct; 65 (1): 53-9